A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers

OBJECTIVE: Fimasartan, an angiotensin II type 1 receptor blocker, and linagliptin, a dipeptidyl-peptidase-4 inhibitor, are frequently coadministered to treat patients with hypertension and diabetes, respectively. This study sought to evaluate the pharmacokinetic interactions between fimasartan and l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Des Devel Ther
Autors principals: Kang, Woo Youl, Lee, Hae Won, Gwon, Mi-Ri, Cho, Seungil, Shim, Wang-Seob, Lee, Kyung-Tae, Yang, Dong Heon, Seong, Sook Jin, Yoon, Young-Ran
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7266304/
https://ncbi.nlm.nih.gov/pubmed/32546973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S248205
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars